SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT: A NEW LOOK AT THE TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND OTHER CAROTID TOPICS
Location: Grand Ballroom West, 3rd Floor
Moderators: TBD
Moderators: TBD
7:50 AM - 7:55 AM
What Facts Would Be Needed To Change My View That All ACS Patients Are Best Treated Medically: Why The CMS Decision To Reimburse Carotid Stenting (CAS) For ACS Patients Was Based On The Wrong Comparative Data (CAS vs CEA When It Should Have Been CAS vs Medical Treatment)
Presenter(s): Anne L. Abbott, MD, PhD, FRACP
Location: Grand Ballroom West, 3rd Floor
7:56 AM - 8:01 AM
Transfemoral CAS (TFCAS) For ACS Is Being Overused Since CMS Expanded Its Reimbursement Without Limits
Presenter(s): Sean P. Lyden, MD
Location: Grand Ballroom West, 3rd Floor
8:02 AM - 8:07 AM
How AI Analysis Of Plaque Features On CT, Ultrasound And MRI Can Predict Stroke Risk More Accurately To Eliminate Unnecessary Invasive Procedures For ACS: While Medical Treatment Is Improving, A Few ACS Patients May Benefit From CAS Or CEA: When Will We Know
Presenter(s): Robert W. Chang, MD
Location: Grand Ballroom West, 3rd Floor
8:08 AM - 8:13 AM
A Neuroradiologist's View Of Current Interventions For Extracranial Carotid Disease: Do They Represent Exuberant Enthusiasm, Financial Opportunity For Industry, Doctors And Institutions, Or A Path To Excessive Risk: Impact Of The Recent Expanded Medicare Reimbursement For CAS
Presenter(s): Colin P. Derdeyn, MD
Location: Grand Ballroom West, 3rd Floor
8:14 AM - 8:19 AM
New Developments In Carotid Plaque Imaging (Duplex, CT, MRI): Can It Predict Stroke Risk Reliably In ACS Patients To Facilitate Highly Selective Invasive Treatment
Presenter(s): Gert J. de Borst, MD, PhD
Location: Grand Ballroom West, 3rd Floor
8:20 AM - 8:25 AM
Should The Amount Of Calcium Play A Role In Decision Making Of Carotid Interventions For ACS: How To Quantitate It And How Does It Influence Outcomes
Presenter(s): Clark J. Zeebregts, MD, PhD
Location: Grand Ballroom West, 3rd Floor
8:26 AM - 8:32 AM
Panel Discussion
Location: Grand Ballroom West, 3rd Floor 8:32 AM - 8:37 AM
What Is The Best Medical Therapy For Patients With Carotid Stenosis: Diet (What Should And Shouldn't Be Eaten) Is Very Important: What Drugs And Dosage Should They Be On And Should They Be Titrated Against LDL Levels: When And How Should Homocysteine Levels Be Reduced
Presenter(s): J. David Spence, MD
Location: Grand Ballroom West, 3rd Floor
8:38 AM - 8:43 AM
All Patients With Carotid Stenosis (Whether Invasively Treated Or Not) Have A High Incidence Of Coronary Artery Disease Which May Be Lethal: A 5-Year RCT Shows That Coronary CT Angiography With Fractional Flow Reserve (FFRCT) Can Lead To Treatment Which Lowers Mortality
Presenter(s): Dainis K. Krievins, MD /
Christopher K. Zarins, MD
Location: Grand Ballroom West, 3rd Floor
8:50 AM - 8:55 AM
If Optimal Skills For Performing CEA, CAS And TCAR Are Available And Invasive Treatment Is Justified, How To Select The Optimal Procedure: This Algorithm Helps
Presenter(s): Adnan H. Siddiqui, MD, PhD /
Andrew N. Nicolaides, MS, FRCS
Location: Grand Ballroom West, 3rd Floor
8:56 AM - 9:01 AM
How Should The Presence Of Severe Renal Dysfunction Or ESRD Influence The Treatment Of Symptomatic Or Asymptomatic Carotid Stenosis
Presenter(s): Rabih A. Chaer, MD
Location: Grand Ballroom West, 3rd Floor
9:02 AM - 9:07 AM
Optimal Current Treatment Of Tandem Extracranial Carotid Lesions: Techniques And Sequence Of Treatment To Include Flow Reversal Cerebral Protection
Presenter(s): Christopher J. Smolock, MD
Location: Grand Ballroom West, 3rd Floor
9:08 AM - 9:14 AM
Panel Discussion
Location: Grand Ballroom West, 3rd Floor 9:15 AM - 9:27 AM
Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)